Dr. Lal PathLabs Q2 Results: Net profit rises 28%, revenue grows 20%; ₹5 interim dividend
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Lal PathLabs shares rose 4% on Wednesday, November 4, after the firm reported strong September quarter results.
- ✓Revenue grew to ₹873.9 crore, while net profit jumped 27.6% to ₹192.2 crore.
- ✓The company also announced a ₹5 interim dividend for shareholders as its stock continues to gain value this year.
Story at a Glance
- Category
- MARKET
- Reported By
- CNBC TV18
- Reading Speed
- 1 Minute(s)
- Market Focus
- India Economy
Shares of Dr. Lal PathLabs Ltd. were trading around 4% higher on Wednesday, November 4, after the diagnostic services provider announced its September quarter (Q2 FY27) results, reporting double-digit growth in revenue, net profit and operating earnings.
The company reported revenue of ₹873.9 crore for the September quarter, marking a 19.6% increase from ₹730.6 crore in the corresponding quarter last year.
Net profit rose 27.6% year-on-year to ₹192.2 crore, compared with ₹150.6 crore in Q2 FY26. EBITDA increased 24.9% to ₹280 crore from ₹224.1 crore a year ago.
The EBITDA margin also improved to 32.1% in the quarter, compared with 30.7% in the year-ago period.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
CNBC TV18
Read the full, original unfiltered story directly on the publisher's portal.